GBP5 exacerbates rosacea-like skin inflammation by skewing macrophage polarization towards M1 phenotype through the NF-KB signalling pathway

被引:40
|
作者
Zhou, Lei [1 ,2 ,3 ]
Zhao, Han [1 ,2 ,3 ]
Zhao, He [1 ,2 ,3 ]
Meng, Xin [1 ,2 ,3 ]
Zhao, Zhixiang [1 ,2 ,3 ]
Xie, Hongfu [1 ,2 ,3 ]
Li, Ji [1 ,2 ,3 ]
Tang, Yan [1 ,2 ,3 ]
Zhang, Yiya [1 ,2 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Hunan Key Lab Aging Biol, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
基金
中国国家自然科学基金;
关键词
PATHOPHYSIOLOGY; ACTIVATION; REVEALS;
D O I
10.1111/jdv.18725
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundRosacea is a chronic inflammatory skin disease with increased macrophage infiltration. However, the molecular mechanism remains unclear. ObjectivesTo determine the significance of macrophage infiltration, and the correlation between Guanylate-binding protein 5 (GBP5) and polarization of macrophages in rosacea-like inflammation. MethodsHere we tested the hypothesis that Guanylate-binding protein 5 (GBP5) aggravates rosacea-like skin inflammation by promoting the polarization of the M1 macrophages through the NF-kappa B signalling pathway. We depleted macrophage by injecting clodronate-containing liposomes. We next explored the association between GBP5 and macrophage in rosacea tissue through transcriptome analysis and immunofluorescence analysis. We evaluated the severity of rosacea-like skin inflammation when BALB/c mice were injected with GBP5 siRNA intradermally daily for three consecutive days. At last, to study the causality of knocking down GBP5-blunted M1 macrophage polarization, THP-1 cell was treated with GBP5 siRNA. ResultsMacrophage depletion ameliorated rosacea-like skin inflammation in mice, implying the important role of macrophages in rosacea. Based on the transcriptome analysis, Guanylate-binding protein 5 (GBP5) was identified as hub gene that was associated with macrophage infiltration in rosacea. Next, we found that GBP5 expression was significantly upregulated in rosacea tissues and positively correlated with macrophage infiltration, the immunofluorescence analysis revealed the co-localization between GBP5 and macrophages. In vivo, silencing of GBP5 attenuated rosacea-like skin inflammation in the LL-37-induced mouse model and suppressed the expression of M1 signature genes such as IL-6, iNOS and TNF-a. In vitro, knocking down GBP5 significantly blunted the polarization of the M1 macrophages partly by repressing the activation of the NF-kappa B signalling pathways. ConclusionsTogether, our study revealed the important role of macrophages in rosacea and identified GBP5 as a key regulator of rosacea by inducing M1 macrophage polarization via NF-kappa B signalling pathways.
引用
收藏
页码:796 / 809
页数:14
相关论文
共 13 条
  • [1] Knockdown of GBP5 alleviates lipid accumulation and inflammation in alcoholic fatty liver through inhibition of NF-KB pathway in mice
    Ma, Jiangyun
    Huang, Jian
    Wei, Xing
    JOURNAL OF MENS HEALTH, 2023, 19 (05) : 21 - 28
  • [2] Inhaled silica nanoparticles exacerbate atherosclerosis through skewing macrophage polarization towards M1 phenotype
    Stachyra, Kamila
    Wisniewska, Anna
    Kiepura, Anna
    Kus, Katarzyna
    Rolski, Filip
    Czepiel, Klaudia
    Chmura, Lukasz
    Majka, Grzegorz
    Surmiak, Marcin
    Polaczek, Justyna
    van Eldik, Rudi
    Suski, Maciej
    Olszanecki, Rafal
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2022, 230
  • [3] Isomeranzin suppresses inflammation by inhibiting M1 macrophage polarization through the NF-κB and ERK pathway
    Xu, Ge
    Feng, Lili
    Song, Pingping
    Xu, Fang
    Li, Ang
    Wang, Yubin
    Shen, Yan
    Wu, Xuefeng
    Luo, Qiong
    Wu, Xingxin
    Sun, Yang
    Wu, Xudong
    Xu, Qiang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 38 : 175 - 185
  • [4] Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-κB Pathway
    Lin, Yi-Hsuan
    Wang, Yi-Hsun
    Peng, Yi-Jen
    Liu, Feng-Cheng
    Lin, Gu-Jiun
    Huang, Shing-Hwa
    Sytwu, Huey-Kang
    Cheng, Chia-Pi
    CELLS, 2020, 9 (04)
  • [5] Oroxylin A suppress LL-37 generated rosacea-like skin inflammation through the modulation of SIRT3-SOD2-NF-KB signaling pathway
    Feng, Chunmei
    Zhang, Haiyan
    Wang, Peiru
    Zhang, Linglin
    Liu, Xiaojing
    Yan, Guorong
    Yan, Yu
    Yang, Jin
    Liu, Jia
    Tan, Fei
    Wang, Xiuli
    Zeng, Qingyu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 129
  • [6] TREM2 promotes macrophage polarization from M1 to M2 and suppresses osteoarthritis through the NF-KB/CXCL3 axis
    Fang, Chao
    Zhong, Rui
    Lu, Shuai
    Yu, Gang
    Liu, Zhilin
    Yan, Chengyuan
    Gao, Jingyu
    Tang, Yang
    Wang, Yingming
    Zhao, Qichun
    Feng, Xinzhe
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (06): : 1992 - 2007
  • [7] miR-345-3p Modulates M1/M2 Macrophage Polarization to Inhibit Inflammation in Bone Infection via Targeting MAP3K1 and NF-kB Pathway
    Dai, Yan
    Yi, Xiaolan
    Huang, Yahui
    Qian, Kaoliang
    Huang, Lili
    Hu, Jun
    Liu, Yuan
    JOURNAL OF IMMUNOLOGY, 2024, 212 (05):
  • [8] Dietary supplementation of n-3 PUFAs ameliorates LL37-induced rosacea-like skin inflammation via inhibition of TLR2/MyD88/ NF-KB pathway
    Shen, Shuzhan
    Yan, Guorong
    Cao, Yajing
    Zeng, Qingyu
    Zhao, Jingjun
    Wang, Xiuli
    Wang, Peiru
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 157
  • [9] Deficiency of IL-7R attenuates abdominal aortic aneurysms in mice by inhibiting macrophage polarization towards M1 phenotype through the NF-κB pathway
    Shengnan Xu
    Xueyu Han
    Yi Yu
    Chuan Qu
    Bo Yang
    Bo Shen
    Xin Liu
    Molecular Medicine, 31 (1)
  • [10] NF-KB p65 and SETDB1 expedite lipopolysaccharide-induced intestinal inflammation in mice by inducing IRF7/NLR-dependent macrophage M1 polarization
    Chen, Li
    Dai, Maolin
    Zuo, Wei
    Dai, Yongyu
    Yang, Qiqi
    Yu, Shuangjiang
    Huang, Min
    Liu, Hao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 115